The interactions of docetaxel with tumor microenvironment
Copyright © 2023 Elsevier B.V. All rights reserved..
There are several interactions within the tumor microenvironment (TME) that affect the response of cancer cells to therapy. There are also a large number of cells and secretions in TME that increase resistance to therapy. Following the release of immunosuppressive, pro-angiogenic, and metastatic molecules by certain cells such as tumor-associated macrophages (TAMs), cancer-associated fibroblasts (CAFs), and cancer cells, immune evasion, angiogenesis, and metastasis may be induced. However, natural killer (NK) cells and cytotoxic CD8 + T lymphocytes (CTLs) can responsively release anticancer molecules. In addition, anticancer drugs can modulate these cells and their interactions in favor of either cancer resistance or therapy. Docetaxel belongs to taxanes, a class of anti-tumor drugs, which acts through the polymerization of tubulin and the induction of cell cycle arrest. Also, it has been revealed that taxanes including docetaxel affect cancer cells and the other cells within TME through some other mechanisms such as modulation of immune system responses, angiogenesis, and metastasis. In this paper, we explain the basic mechanisms of docetaxel interactions with malignant cells. Besides, we review the diverse effects of docetaxel on TME and cancer cells in consequence. Lastly, the modulatory effects of docetaxel alone or in conjunction with other anticancer agents on anti-tumor immunity, cancer cell resistance, angiogenesis, and metastasis will be discussed.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:119 |
---|---|
Enthalten in: |
International immunopharmacology - 119(2023) vom: 20. Juni, Seite 110214 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Gupta, Reena [VerfasserIn] |
---|
Links: |
---|
Themen: |
15H5577CQD |
---|
Anmerkungen: |
Date Completed 01.06.2023 Date Revised 01.06.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.intimp.2023.110214 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM356303373 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM356303373 | ||
003 | DE-627 | ||
005 | 20231226070156.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.intimp.2023.110214 |2 doi | |
028 | 5 | 2 | |a pubmed24n1187.xml |
035 | |a (DE-627)NLM356303373 | ||
035 | |a (NLM)37126985 | ||
035 | |a (PII)S1567-5769(23)00535-0 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Gupta, Reena |e verfasserin |4 aut | |
245 | 1 | 4 | |a The interactions of docetaxel with tumor microenvironment |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 01.06.2023 | ||
500 | |a Date Revised 01.06.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023 Elsevier B.V. All rights reserved. | ||
520 | |a There are several interactions within the tumor microenvironment (TME) that affect the response of cancer cells to therapy. There are also a large number of cells and secretions in TME that increase resistance to therapy. Following the release of immunosuppressive, pro-angiogenic, and metastatic molecules by certain cells such as tumor-associated macrophages (TAMs), cancer-associated fibroblasts (CAFs), and cancer cells, immune evasion, angiogenesis, and metastasis may be induced. However, natural killer (NK) cells and cytotoxic CD8 + T lymphocytes (CTLs) can responsively release anticancer molecules. In addition, anticancer drugs can modulate these cells and their interactions in favor of either cancer resistance or therapy. Docetaxel belongs to taxanes, a class of anti-tumor drugs, which acts through the polymerization of tubulin and the induction of cell cycle arrest. Also, it has been revealed that taxanes including docetaxel affect cancer cells and the other cells within TME through some other mechanisms such as modulation of immune system responses, angiogenesis, and metastasis. In this paper, we explain the basic mechanisms of docetaxel interactions with malignant cells. Besides, we review the diverse effects of docetaxel on TME and cancer cells in consequence. Lastly, the modulatory effects of docetaxel alone or in conjunction with other anticancer agents on anti-tumor immunity, cancer cell resistance, angiogenesis, and metastasis will be discussed | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Angiogenesis | |
650 | 4 | |a Cancer | |
650 | 4 | |a Docetaxel | |
650 | 4 | |a Immune system | |
650 | 4 | |a Tumor Microenvironment (TME) | |
650 | 7 | |a Docetaxel |2 NLM | |
650 | 7 | |a 15H5577CQD |2 NLM | |
650 | 7 | |a Antineoplastic Agents |2 NLM | |
700 | 1 | |a Kadhim, Mustafa M |e verfasserin |4 aut | |
700 | 1 | |a Turki Jalil, Abduladheem |e verfasserin |4 aut | |
700 | 1 | |a Qasim Alasheqi, Mohammed |e verfasserin |4 aut | |
700 | 1 | |a Alsaikhan, Fahad |e verfasserin |4 aut | |
700 | 1 | |a Khalimovna Mukhamedova, Nurkhan |e verfasserin |4 aut | |
700 | 1 | |a Alexis Ramírez-Coronel, Andrés |e verfasserin |4 aut | |
700 | 1 | |a Hassan Jawhar, Zanko |e verfasserin |4 aut | |
700 | 1 | |a Ramaiah, Pushpamala |e verfasserin |4 aut | |
700 | 1 | |a Najafi, Masoud |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t International immunopharmacology |d 2001 |g 119(2023) vom: 20. Juni, Seite 110214 |w (DE-627)NLM112639542 |x 1878-1705 |7 nnns |
773 | 1 | 8 | |g volume:119 |g year:2023 |g day:20 |g month:06 |g pages:110214 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.intimp.2023.110214 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 119 |j 2023 |b 20 |c 06 |h 110214 |